Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Pluristyx Announces License Agreement with Humacyte; Humacyte to Use Pluristyx's Clinical-Grade PluriBank iPSC Line for Manufacturing Insulin-Producing Cells for BioVascular Pancreas Product

Author: Benzinga Newsdesk | July 09, 2024 10:07am

Partnership Includes Access to panCELLa™ Platform for Generating Hypoimmune Cells for Clinical Implantation

Posted In: HUMA